XNASAIRS
Market cap285mUSD
Jan 16, Last price
4.93USD
1D
-1.40%
1Q
-16.86%
IPO
-66.00%
Name
Airsculpt Technologies Inc
Chart & Performance
P/E
—
P/S
1.46
EPS
—
Div Yield, %
0.16%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
196m
+16.07%
Net income
-4m
L-69.49%
CFO
24m
-2.01%
Dividend
Aug 25, 20220.41 USD/sh
Earnings
Feb 25, 2025
Profile
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
IPO date
Oct 29, 2021
Employees
291
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 195,917 16.07% | 168,794 26.61% | |||
Cost of revenue | 182,293 | 164,199 | |||
Unusual Expense (Income) | |||||
NOPBT | 13,624 | 4,595 | |||
NOPBT Margin | 6.95% | 2.72% | |||
Operating Taxes | 7,477 | 3,383 | |||
Tax Rate | 54.88% | 73.62% | |||
NOPAT | 6,147 | 1,212 | |||
Net income | (4,479) -69.49% | (14,679) -239.12% | |||
Dividends | (464) | (24,319) | |||
Dividend yield | 0.11% | 11.80% | |||
Proceeds from repurchase of equity | (233) | (2,031) | |||
BB yield | 0.05% | 0.99% | |||
| Debt | |||||
Debt current | 12,875 | 6,481 | |||
Long-term debt | 120,208 | 125,266 | |||
Deferred revenue | |||||
Other long-term liabilities | 716 | 1,025 | |||
Net debt | 122,821 | 130,560 | |||
| Cash flow | |||||
Cash from operating activities | 23,956 | 24,447 | |||
CAPEX | (9,919) | (12,921) | |||
Cash from investing activities | (9,919) | (12,921) | |||
Cash from financing activities | (13,391) | (27,257) | |||
FCF | (535) | (14,972) | |||
| Balance | |||||
Cash | 10,262 | 9,616 | |||
Long term investments | (8,429) | ||||
Excess cash | 466 | ||||
Stockholders' equity | (19,906) | (15,092) | |||
Invested Capital | 211,729 | 194,529 | |||
ROIC | 3.03% | 0.64% | |||
ROCE | 6.86% | 2.48% | |||
| EV | |||||
Common stock shares outstanding | 56,779 | 55,685 | |||
Price | 7.49 102.43% | 3.70 -78.48% | |||
Market cap | 425,273 106.41% | 206,033 -78.46% | |||
EV | 548,094 | 336,593 | |||
EBITDA | 23,877 | 12,656 | |||
EV/EBITDA | 22.95 | 26.60 | |||
Interest | 6,485 | 6,751 | |||
Interest/NOPBT | 47.60% | 146.92% | |||